DOHA, Qatar, June 21 /PRNewswire-FirstCall/ -- One of the leading cancer centers in the Middle East has become among the first in the region to introduce fast and efficient RapidArc® radiotherapy treatments from Varian Medical Systems (NYSE: VAR). Al Amal Hospital in Doha, Qatar, has treated nine brain cancer, prostate cancer and head & neck cancer patients with RapidArc since commencing treatments in early May, and it now plans to roll out the technology for many more indications.
"Faster treatments that adapt radiation dose to the tumor are always desirable in radiotherapy and we are very proud to join other prominent oncology centers worldwide in offering this technology," says Dr. Noora Al Hammadi, director of Al Amal Hospital's radiation oncology program.
"State-of-the-art capabilities such as RapidArc offer our patients a fast and efficient way of receiving more advanced radiotherapy treatments. Since we introduced RapidArc on our two Varian linear accelerators, we have widened the indications that we treat with the technique and we expect this trend to continue as it becomes more and more a part of our center's routine treatment approach. We are very pleased about the potential of this technology."
This achievement was recognized at a grand opening ceremony at the hospital on Saturday, attended by members of the Qatari Royal Family and government. During the ceremony, Al Amal Hospital signed an agreement with Varian for the hospital to become a reference center in the gulf region and the Middle East for RapidArc, image-guided radiotherapy (IGRT) and other advanced forms of radiotherapy.
"Al Amal Hospital is a great exa